The iShares U.S. Pharmaceuticals ETF (IHE) has a lower expense ratio and a higher dividend than the Invesco Pharmaceuticals ETF (PJP). The update is primarily comparative fund positioning information and is unlikely to materially move broad pharmaceutical equity prices.
The iShares U.S. Pharmaceuticals ETF (IHE) has a lower expense ratio and a higher dividend than the Invesco Pharmaceuticals ETF (PJP). The update is primarily comparative fund positioning information and is unlikely to materially move broad pharmaceutical equity prices.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05